$202.85
3.86% today
NYSE, Feb 19, 09:15 pm CET
ISIN
US9553061055
Symbol
WST

West Pharmaceutical Services, Inc. Stock price

$211.00
-125.34 37.27% 1M
-90.68 30.06% 6M
-116.56 35.58% YTD
-151.05 41.72% 1Y
-158.49 42.89% 3Y
+37.78 21.81% 5Y
+158.64 302.98% 10Y
NYSE, Closing price Tue, Feb 18 2025
-3.73 1.74%
ISIN
US9553061055
Symbol
WST
Sector

Key metrics

Market capitalization $15.28b
Enterprise Value $15.00b
P/E (TTM) P/E ratio 31.52
EV/Sales (TTM) EV/Sales 5.18
P/S ratio (TTM) P/S ratio 5.28
P/B ratio (TTM) P/B ratio 5.56
Dividend yield 0.39%
Last dividend (FY24) $0.82
Revenue growth (TTM) Revenue growth -1.92%
Revenue (TTM) Revenue $2.89b
EBIT (operating result TTM) EBIT $585.20m
Cash position $490.90m
EPS (TTM) EPS $6.69
P/E forward 35.02
P/S forward 5.27
EV/Sales forward 5.17
Short interest 2.43%
Show more

Is West Pharmaceutical Services, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,823 stocks worldwide.

West Pharmaceutical Services, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

10x Buy
71%
4x Hold
29%

Analyst Opinions

14 Analysts have issued a West Pharmaceutical Services, Inc. forecast:

Buy
71%
Hold
29%

Financial data from West Pharmaceutical Services, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
2,893 2,893
2% 2%
100%
- Direct Costs 1,892 1,892
4% 4%
65%
1,116 1,116
1% 1%
39%
- Selling and Administrative Expenses 347 347
66% 66%
12%
- Research and Development Expense 69 69
1% 1%
2%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 585 585
18% 18%
20%
Net Profit 493 493
17% 17%
17%

In millions USD.

Don't miss a Thing! We will send you all news about West Pharmaceutical Services, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

West Pharmaceutical Services, Inc. Stock News

Positive
Seeking Alpha
3 days ago
The price of West Pharmaceutical Services plunged over 38% after it released its Q4 and FY 2024 earnings results on February 13. Shareholders, mostly institutional investors apparently, did not like the bottom-line results nor the uninspiring guidance for 2025. Still, West should not be overlooked, and there may be opportunities if the share price continues to rebound after a market overreaction.
Positive
Forbes
5 days ago
West Pharmaceutical Services, a global provider of solutions for drugs, biologics, gene therapies, and consumer healthcare products, recently announced its Q4 results, surpassing analysts' expectations for both revenue and earnings. The company reported sales of $749 million and adjusted earnings per share of $1.82, compared to $740 million and $1.73, respectively.
Neutral
Seeking Alpha
6 days ago
West Pharmaceutical Services, Inc. (NYSE:WST ) Q4 2024 Earnings Conference Call February 13, 2025 9:00 AM ET Company Participants John Sweeney - Vice President of Investor Relations Eric Green - Chairman, President & Chief Executive Officer Bernard Birkett - Senior Vice President & Chief Financial Officer Conference Call Participants Michael Ryskin - BofA Global Research Lawrence Solow - CJS Se...
More West Pharmaceutical Services, Inc. News

Company Profile

West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Head office United States
CEO Eric Green
Founded 1923
Website www.westpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today